HVC

Healthcare Value Capital Portfolio holdings

AUM $38.5M
This Quarter Return
+12.53%
1 Year Return
+22.29%
3 Year Return
+31.09%
5 Year Return
+125.72%
10 Year Return
–
AUM
$25.9M
AUM Growth
+$25.9M
Cap. Flow
-$3.92M
Cap. Flow %
-15.1%
Top 10 Hldgs %
92.89%
Holding
18
New
1
Increased
1
Reduced
1
Closed
1

Top Buys

1
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
$420K
2
VYNE icon
VYNE Therapeutics
VYNE
$316K

Top Sells

1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
$2.48M
2
SPXU icon
ProShares UltraPro Short S&P 500
SPXU
$2.18M

Sector Composition

1 Healthcare 94.51%
2 Consumer Staples 3.82%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ABBV icon
1
AbbVie
ABBV
$372B
$3.75M 12.63% 35,000 – –
GSK icon
2
GSK
GSK
$79.9B
$3.68M 12.4% 100,000 – –
VYNE icon
3
VYNE Therapeutics
VYNE
$8.16M
$3.16M 10.65% 2,000,000 +200,000 +11% +$316K
GILD icon
4
Gilead Sciences
GILD
$140B
$2.91M 9.81% 50,000 – –
TYME
5
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$2.65M 8.94% 2,175,000 – –
ATRS
6
DELISTED
Antares Pharma, Inc.
ATRS
$2M 6.72% 500,000 – –
MCK icon
7
McKesson
MCK
$85.4B
$1.74M 5.86% 10,000 – –
JAZZ icon
8
Jazz Pharmaceuticals
JAZZ
$7.75B
$1.65M 5.56% 10,000 -15,000 -60% -$2.48M
CAH icon
9
Cardinal Health
CAH
$35.5B
$1.34M 4.51% 25,000 – –
CLVS
10
DELISTED
Clovis Oncology, Inc.
CLVS
$1.2M 4.04% 250,000 – –
GNLN icon
11
Greenlane Holdings
GNLN
$4.71M
$990K 3.34% 250,000 – –
ADMS
12
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$433K 1.46% 100,000 – –
GMDA
13
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$420K 1.42% +50,000 New +$420K
AMRN
14
Amarin Corp
AMRN
$311M
– – 0 – –
MRNA icon
15
Moderna
MRNA
$9.37B
– – 0 – –
NVAX icon
16
Novavax
NVAX
$1.21B
– – 0 – –
SPXU icon
17
ProShares UltraPro Short S&P 500
SPXU
$527M
– – -250,000 Closed -$2.18M
VIXY icon
18
ProShares VIX Short-Term Futures ETF
VIXY
$87.1M
– – 0 – –